Matrixport: As Bitcoin Dominance Strengthens, Hopes for Altcoin Rebound Gradually Fade
ChainCatcher reports that Matrixport stated on Platform X that over the past year, crypto Twitter has been calling for altcoin rebounds almost every month, but without success. However, altcoin rebounds are not driven by chart patterns or some assumed lag behind Bitcoin's movements. Instead, they rely on the decline of Bitcoin's dominance and the rise in total cryptocurrency market capitalization.
As Bitcoin's dominance climbs, Ethereum underperforms, and few other cryptocurrencies have emerged as credible competitors in this cycle. Without strong alternative narratives or leadership, other cryptocurrencies may continue to lag. Our other cryptocurrency performance models currently support this view, remaining optimistic about Bitcoin.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Just about three months after listing, two SK Hynix leveraged ETFs are set to be delisted in the United States.
Tradr ETFs announced that its two leveraged products linked to SK Hynix ADRs will be liquidated and delisted around November 12, with one being long and the other short. Despite only being listed for a few months, their combined scale has shrunk to about $1.3 million, down more than 60% from their peak. SK Hynix's Seoul stock price has fallen 56% from its high, similar products in the industry are generally under pressure, and South Korea has also further tightened regulations on leveraged products.

WTI Price Forecast: Slides further below $100.50; bullish potential seems intact
A $5 billion single-product emerges? JPMorgan maintains a "Neutral" rating on Amgen (AMGN.US): A good drug doesn't necessarily mean a good buying opportunity.
Amgen's Imdelltra has maintained data with an HR of 0.42, nearly doubling survival time. Morgan Stanley estimates that it will become a single product with annual sales of around 5 billions USD. However, they maintain a Neutral rating and a target price of 350 USD.

